Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, ...

Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long ...

Colossal Biosciences raises $200 million, valued at $10.2 billion. Animal Capital's $400,000 investment now worth $50 million ...

The woolly mammoth has been extinct for thousands of years, but Colossal Biosciences is pursuing technology that could help ...

The World Economic Forum predicts that biodiversity loss could cause a colossal decline in global GDP of $2.7 trillion ...

GUAC is Manuel’s response to his overwhelming grief, his love for his son, and his call to be an activist fighting for gun ...

The life-sized woolly mammoth fossil sitting inside the Natural History Society of Maryland has the wow factor for those who ...

India's rich biodiversity offers unique opportunities for Colossal Biosciences to revive extinct species like the woolly ...

Colossal Biosciences announced Wednesday it had raised $200 million in Series C funding round led by TWG Global for its ...